Literature DB >> 22978711

Recurrent mutations in DNAJC5 cause autosomal dominant Kufs disease.

M Cadieux-Dion1, E Andermann, P Lachance-Touchette, O Ansorge, C Meloche, A Barnabé, R I Kuzniecky, F Andermann, E Faught, S Leonberg, J A Damiano, S F Berkovic, G A Rouleau, P Cossette.   

Abstract

We sought to identify the molecular basis of the autosomal dominant form of Kufs disease, an adult onset form of neuronal ceroid lipofuscinosis. We used a combination of classic linkage analysis and Next Generation Sequencing to map and identify mutations in DNAJC5 in a total of three families. We analyzed the clinical manifestations in 20 individuals with mutation in DNAJC5. We report here the mapping and the identification of a p.L116del mutation in DNAJC5 segregating with the disease in two distinct American families, as well as a p.L115R mutation in an additional family. The age of onset and clinical manifestations were very homogeneous among mutation positive individuals, including generalized tonic-clonic seizures, myoclonus, ataxia, speech deterioration, dementia, and premature death. A few individuals also exhibited parkinsonism. DNAJC5, which encodes the cysteine string protein (CSPα), a presynaptic protein implicated in neurodegeneration, causes autosomal dominant Kufs disease. The leucine residues at positions 115 and 116 are hotspots for mutations and result in a homogeneous phenotype of progressive myoclonus epilepsy with onset around 30 years old.
© 2012 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22978711     DOI: 10.1111/cge.12020

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  26 in total

1.  A novel p.Leu(381)Phe mutation in presenilin 1 is associated with very early onset and unusually fast progressing dementia as well as lysosomal inclusions typically seen in Kufs disease.

Authors:  Natalia Dolzhanskaya; Michael A Gonzalez; Fiorella Sperziani; Shannon Stefl; Jeffrey Messing; Guang Y Wen; Emil Alexov; Stephan Zuchner; Milen Velinov
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

2.  Diagnosis and misdiagnosis of adult neuronal ceroid lipofuscinosis (Kufs disease).

Authors:  Samuel F Berkovic; John F Staropoli; Stirling Carpenter; Karen L Oliver; Stanislav Kmoch; Glenn W Anderson; John A Damiano; Michael S Hildebrand; Katherine B Sims; Susan L Cotman; Melanie Bahlo; Katherine R Smith; Maxime Cadieux-Dion; Patrick Cossette; Ivana Jedličková; Anna Přistoupilová; Sara E Mole
Journal:  Neurology       Date:  2016-07-13       Impact factor: 9.910

3.  Adult-onset autosomal recessive ataxia associated with neuronal ceroid lipofuscinosis type 5 gene (CLN5) mutations.

Authors:  Cecilia Mancini; Stefano Nassani; Yiran Guo; Yulan Chen; Elisa Giorgio; Alessandro Brussino; Eleonora Di Gregorio; Simona Cavalieri; Nicola Lo Buono; Ada Funaro; Nicola Renato Pizio; Bruce Nmezi; Aija Kyttala; Filippo Maria Santorelli; Quasar Salem Padiath; Hakon Hakonarson; Hao Zhang; Alfredo Brusco
Journal:  J Neurol       Date:  2014-10-31       Impact factor: 4.849

4.  Genetic Analysis of HSP40/DNAJ Family Genes in Parkinson's Disease: a Large Case-Control Study.

Authors:  Kailin Zhang; Hongxu Pan; Yuwen Zhao; Yige Wang; Qian Zeng; Xun Zhou; Runcheng He; Xiaoxia Zhou; Yaqin Xiang; Zhou Zhou; Yu Li; Qian Xu; Qiying Sun; Jieqiong Tan; Xinxiang Yan; Jinchen Li; Jifeng Guo; Beisha Tang; Zhenhua Liu
Journal:  Mol Neurobiol       Date:  2022-06-17       Impact factor: 5.682

Review 5.  Neuronal ceroid lipofuscinosis: impact of recent genetic advances and expansion of the clinicopathologic spectrum.

Authors:  Susan L Cotman; Amel Karaa; John F Staropoli; Katherine B Sims
Journal:  Curr Neurol Neurosci Rep       Date:  2013-08       Impact factor: 5.081

Review 6.  Autosomal dominant neuronal ceroid lipofuscinosis: Clinical features and molecular basis.

Authors:  Nima Naseri; Manu Sharma; Milen Velinov
Journal:  Clin Genet       Date:  2020-08-26       Impact factor: 4.438

7.  Neuronal ceroid lipofuscinosis with DNAJC5/CSPα mutation has PPT1 pathology and exhibit aberrant protein palmitoylation.

Authors:  Michael X Henderson; Gregory S Wirak; Yong-Quan Zhang; Feng Dai; Stephen D Ginsberg; Natalia Dolzhanskaya; John F Staropoli; Peter C G Nijssen; TuKiet T Lam; Amy F Roth; Nicholas G Davis; Glyn Dawson; Milen Velinov; Sreeganga S Chandra
Journal:  Acta Neuropathol       Date:  2015-12-10       Impact factor: 17.088

Review 8.  Myoclonus-Ataxia Syndromes: A Diagnostic Approach.

Authors:  Malco Rossi; Sterre van der Veen; Marcelo Merello; Marina A J Tijssen; Bart van de Warrenburg
Journal:  Mov Disord Clin Pract       Date:  2020-11-03

Review 9.  DNAJC proteins and pathways to parkinsonism.

Authors:  Dorien A Roosen; Cornelis Blauwendraat; Mark R Cookson; Patrick A Lewis
Journal:  FEBS J       Date:  2019-06-20       Impact factor: 5.622

Review 10.  DNAJ Proteins in neurodegeneration: essential and protective factors.

Authors:  Christina Zarouchlioti; David A Parfitt; Wenwen Li; Lauren M Gittings; Michael E Cheetham
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2018-01-19       Impact factor: 6.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.